TY  - JOUR 
AU  - Verger, A.
AU  - Yakushev, I.
AU  - Albert, N.L.
AU  - van Berckel, B.
AU  - Brendel, M.
AU  - Cecchin, D.
AU  - Aguiar Fernández, Pablo
AU  - Fraioli, F.
AU  - Guedj, E.
AU  - Morbelli, S.
AU  - Tolboom, N.
AU  - Traub-Weidinger, T.
AU  - Van Weehaeghe, D.
AU  - Barthel, H.
PY  - 2023
SN  - 1619-7089
UR  - http://hdl.handle.net/20.500.11940/21502
LA  - eng
KW  - Humans
KW  - Neuroimaging
KW  - Positron-Emission Tomography
KW  - Amyloid
KW  - Alzheimer Disease
KW  - Amyloid beta-Peptides
TI  - FDA approval of lecanemab: the real start of widespread amyloid PET use? - the EANM Neuroimaging Committee perspective
DO  - 10.1007/s00259-023-06177-5
T2  - European Journal of Nuclear Medicine and Molecular Imaging
M2  - 1553
KW  - AS Santiago
KW  - IDIS
VL  - 50
ER  -